This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Escherichia coli is a probiotic indicated to treat urinary tract infections and irritable bowel syndrome.
- Generic Name
- Escherichia coli
- DrugBank Accession Number
- DB16539
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Asymptomatic bacteriuria •••••••••••• ••••••• Treatment of Irritable bowel syndrome (ibs) ••• ••• •••••••• • ••••• Treatment of Pyelonephritis •••••••••••• ••••••• Treatment of Urethritis •••••••••••• ••••••• Treatment of Urinary tract infection •••••••••••• ••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 514B9K0L10
- CAS number
- 68583-22-2
References
- General References
- External Links
- 350202
- Wikipedia
- Escherichia_coli
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Cervical Cancer / Cervical Intraepithelial Neoplasia (CIN) / Persistent Infection / Vaginal Intraepithelial Neoplasia / Vulvar Intraepithelial Neoplasia (VIN) 1 4 Completed Prevention Hepatitis E 4 4 Completed Treatment Endotoxin, Escherichia Coli / Regional Blood Flow / Retina 1 3 Active Not Recruiting Prevention Human Papillomavirus (HPV) Infections 3 2 Completed Not Available Diarrhea 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution / drops Oral Capsule Oral 6 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 02, 2021 22:27 / Updated at May 05, 2021 20:32